All In Biotech

Drug Trial Radar · NCT04023396

Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

A Phase 2b, Open-label, Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

217

Actual

Start

Jan 13, 2020

Primary completion

Feb 23, 2023

Study completion Feb 23, 2023

Sponsor

Lead sponsor
Abivax S.A.Industry
Sponsor type
Industry
First posted
Jul 17, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase 2b study to evaluate the long-term efficacy and safety study of ABX464 50mg as maintenance therapy in patients with moderate to severe Ulcerative Colitis.

Conditions

  • Ulcerative Colitis

Interventions

  • ABX464Drug

    ABX464 All subjects will receive ABX464 administered at 50 mg o.d for an overall period of 96 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Patients With Clinical Remission at Week 48 Compared to Baseline of Induction Study (ABX464-103)Time frame: week 48

Locations

120 sites in 16 countries. Site status is shown where the registry gives one.

  • Medizinische Universität Innsbruck

    Innsbruck, Austria

  • Klinikum Klagenfurt am Wörthersee

    Klagenfurt, Austria

  • Ordensklinikum Linz GmbH - Barmherzige Schwestern

    Linz, Austria

  • AKH - Medizinische Universität Wien

    Vienna, Austria

  • Gomel Regional Clinical Hospital

    Homyel, Belarus

  • Minsk city diagnostic center

    Minsk, Belarus

  • Regional Clinical Hospital

    Minsk, Belarus

  • Vitebsk Regional Clinical Hospital

    Vitebsk, Belarus

  • Vitebsk regoinal clinical specialized center

    Vitebsk, Belarus

  • AZ Sint-Lucas

    Bruges, Belgium

  • C. H. U. St-Pierre

    Brussels, Belgium

  • University Hospitals Leuven - campus Gasthuisberg

    Leuven, Belgium

  • Brandon Medical Arts Clinic

    Brandon, Canada

  • South Edmonton Gastroenterology

    Edmonton, Canada

  • LHSC - Victoria Hospital

    London, Canada

  • The Ottawa Hospital - General Campus

    Ottawa, Canada

  • Mount Sinai Hospital

    Toronto, Canada

  • Fakultni nemocnice u sv. Anny v Brne

    Brno, Czechia

  • Hepato-Gastroenterologie HK s.r.o.

    Hradec Králové, Czechia

  • MUDr. GREGAR s.r.o.

    Olomouc, Czechia

  • Fakultni nemocnice Ostrava

    Ostrava-Kunčice, Czechia

  • Nemocnice Na Bulovce

    Prague, Czechia

  • Thomayerova nemocnice

    Prague, Czechia

  • Nemocnice Slany

    Slaný, Czechia

  • CHU Amiens - Hopital Sud

    Amiens, France

  • CHU Besançon - Hôpital Jean Minjoz

    Besançon, France

  • CHU Clermont Ferrand - Hôpital d'Estaing

    Clermont-Ferrand, France

  • Hôpital Beaujon

    Clichy, France

  • CHU de Grenoble - Hôpital Nord

    Grenoble, France

  • Centre Hospitalier Départemental Les Oudairies

    La Roche-sur-Yon, France

  • CHU Lille - Hôpital Claude Huriez

    Lille, France

  • Hôpital Nord - CHU Marseille

    Marseille, France

  • Hopital Saint Eloi

    Montpellier, France

  • CHU Nantes - Hôtel Dieu

    Nantes, France

  • CHU Nice - Hôpital de l'Archet 2

    Nice, France

  • CHU Reims - Hôpital Robert Debré

    Reims, France

  • CHU Rennes - Hôpital Pontchaillou

    Rennes, France

  • CHU de Rouen - Hôpital Charles Nicolle

    Rouen, France

  • CHU Saint Etienne - Hôpital Nord

    Saint-Etienne, France

  • CHU Strasbourg - Hôpital Hautepierre

    Strasbourg, France

Showing 40 of 120 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.